Introduction
The document introduces the CYCLO G6™ Glaucoma Laser System, featuring MicroPulse® technology for innovative cyclophotocoagulation. This system is designed to be safe, efficacious, efficient, and economical for glaucoma treatment.

MicroPulse Technology
MicroPulse technology controls thermal elevation by dividing a continuous-wave laser beam into short pulses, allowing tissue cooling between pulses to prevent damage. This technology is highlighted for its safety and efficacy in intraocular pressure (IOP) control.

Clinical Efficacy
Results from a clinical study at National University Hospital, Singapore, show a 33% reduction in IOP at 18 months with a 73% success rate. The device is noted for its effectiveness in patients non-compliant with medication.

Safety Profile
The MicroPulse P3 device offers a non-incisional, repeatable, and predictable procedure with minimal post-operative inflammation and low patient downtime.

Device Options and Comparisons
The document compares the MicroPulse P3 and G-Probe™ devices, both used for laser energy delivery in glaucoma treatment. The MicroPulse P3 is noted for its non-destructive nature and repeatability.

Clinical Study Data
Data from a multi-center retrospective study shows significant IOP reduction with the MicroPulse P3 device, with no detectable tissue damage post-treatment.

Technical Specifications
The CYCLO G6 system features a wavelength of 810 nm, a weight of 3.9 kg, and dimensions of 27 cm x 29.5 cm x 19.7 cm. It includes a color LCD touchscreen interface and supports single-use devices only.

Ordering Information
The document provides product numbers and packaging details for ordering the MicroPulse P3 and G-Probe™ devices.